SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Carbogen Amc - Quaterly Results

13 Nov 2024 Evaluate
The turnover zoomed to Rs. 932.90 millions, up 56.21% for the September 2024 quarter as against Rs. 597.20 millions during the year-ago period.The Total Profit for the quarter ended September 2024 of Rs. 142.50 millions grew from Rs.-57.80 millionsOperating Profit saw a handsome growth to 373.30 millions from 357.90 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 932.90 597.20 56.21 1967.00 1292.70 52.16 3273.50 4025.50 -18.68
Other Income 239.30 387.10 -38.18 355.20 531.50 -33.17 630.50 521.60 20.88
PBIDT 373.30 357.90 4.30 638.20 452.10 41.16 698.50 599.20 16.57
Interest 155.90 174.20 -10.51 313.20 351.80 -10.97 681.90 579.20 17.73
PBDT 217.40 153.20 41.91 325.00 69.80 365.62 -13.90 0.00 0.00
Depreciation 163.00 245.80 -33.69 326.20 492.70 -33.79 1016.10 962.00 5.62
PBT 54.40 -92.60 -158.75 -1.20 -422.90 -99.72 -1030.00 -962.00 7.07
TAX -88.10 -34.80 153.16 -109.00 -151.80 -28.19 -265.90 -373.30 -28.77
Deferred Tax -88.10 -34.80 153.16 -109.00 -151.80 -28.19 -376.50 -373.30 0.86
PAT 142.50 -57.80 -346.54 107.80 -271.10 -139.76 -764.10 -588.70 29.79
Equity 313.60 313.60 0.00 313.60 313.60 0.00 313.60 313.60 0.00
PBIDTM(%) 40.02 59.93 -33.23 32.45 34.97 -7.23 21.34 14.89 43.35

Dishman Carbogen Amc Share Price

167.55 -1.05 (-0.62%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×